Literature DB >> 15583344

Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the VITEK 2 instrument.

J H Jorgensen1, S A Crawford, L M McElmeel, C G Whitney.   

Abstract

A group of 72 pneumococcal isolates resistant or intermediate to levofloxacin and 124 pneumococcal isolates susceptible to fluoroquinolones were tested by the VITEK 2 instrument using investigational test cards and by a broth microdilution reference method. The VITEK 2 instrument performed well, detecting 52 of 60 (86.7%) gatifloxacin-resistant isolates and 22 of 23 moxifloxacin-resistant isolates, and did not falsely classify any susceptible isolates as resistant.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15583344      PMCID： PMC535296          DOI： 10.1128/JCM.42.12.5928-5930.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Fatal meningitis due to levofloxacin-resistant Streptococcus pneumoniae.

Authors:  G W Wortmann; S P Bennett
Journal:  Clin Infect Dis       Date:  1999-12       Impact factor: 9.079

2.  Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of the bioMerieux VITEK 2.

Authors:  J H Jorgensen; A L Barry; M M Traczewski; D F Sahm; M L McElmeel; S A Crawford
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

3.  Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention.

Authors:  M S Niederman; L A Mandell; A Anzueto; J B Bass; W A Broughton; G D Campbell; N Dean; T File; M J Fine; P A Gross; F Martinez; T J Marrie; J F Plouffe; J Ramirez; G A Sarosi; A Torres; R Wilson; V L Yu
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

4.  Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group.

Authors:  L A Mandell; T J Marrie; R F Grossman; A W Chow; R H Hyland
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

5.  Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.

Authors:  C G Whitney; M M Farley; J Hadler; L H Harrison; C Lexau; A Reingold; L Lefkowitz; P R Cieslak; M Cetron; E R Zell; J H Jorgensen; A Schuchat
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

6.  Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study.

Authors:  P L Ho; W S Tse; K W Tsang; T K Kwok; T K Ng; V C Cheng; R M Chan
Journal:  Clin Infect Dis       Date:  2001-02-28       Impact factor: 9.079

7.  Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

Authors:  D K Chen; A McGeer; J C de Azavedo; D E Low
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

8.  Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community.

Authors:  Benjamin A Kupronis; Chesley L Richards; Cynthia G Whitney
Journal:  J Am Geriatr Soc       Date:  2003-11       Impact factor: 5.562

9.  Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.

Authors:  G V Doern; A B Brueggemann; H Huynh; E Wingert
Journal:  Emerg Infect Dis       Date:  1999 Nov-Dec       Impact factor: 6.883

10.  Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci.

Authors:  J H Jorgensen; L M Weigel; M J Ferraro; J M Swenson; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191
View more
  3 in total

1.  Comparative evaluation of a new Vitek 2 system for identification and antimicrobial susceptibility testing of Streptococcus pneumoniae.

Authors:  M Abele-Horn; K Stoy; M Frosch; R R Reinert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-01       Impact factor: 3.267

2.  Comparison of BD phoenix to vitek 2, microscan MICroSTREP, and Etest for antimicrobial susceptibility testing of Streptococcus pneumoniae.

Authors:  Scott A Mittman; Richard C Huard; Phyllis Della-Latta; Susan Whittier
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

3.  Multicenter evaluation of the BD Phoenix Automated Microbiology System for antimicrobial susceptibility testing of Streptococcus species.

Authors:  Sandra S Richter; Wanita J Howard; Melvin P Weinstein; David A Bruckner; Janet F Hindler; Michael Saubolle; Gary V Doern
Journal:  J Clin Microbiol       Date:  2007-07-25       Impact factor: 5.948
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.